100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Certified Clinical Research Professional (CCRP) Exam| ALL QUESTIONS CORRECTLY ANSWERED $10.49   Add to cart

Exam (elaborations)

Certified Clinical Research Professional (CCRP) Exam| ALL QUESTIONS CORRECTLY ANSWERED

 19 views  1 purchase
  • Course
  • Institution

When isn't an IND application needed? Correct Answer: IND Application is not needed if investigation does not support change in labeling What information must the general IND include? (21 CFR Part 312.23) Correct Answer: FDA Form 1571: -FDA Form 1571 cover sheet -Table of contents -Investig...

[Show more]

Preview 2 out of 6  pages

  • September 30, 2022
  • 6
  • 2022/2023
  • Exam (elaborations)
  • Questions & answers
avatar-seller
Certified Clinical Research Professional (CCRP) Exam|
ALL QUESTIONS CORRECTLY ANSWERED
When isn't an IND application needed? Correct Answer: IND Application is not needed if
investigation does not support change in labeling

What information must the general IND include? (21 CFR Part 312.23) Correct Answer: FDA
Form 1571:
-FDA Form 1571 cover sheet
-Table of contents
-Investigative plan
-Investigator's brochure
-Protocol
-Chemistry/Manufacturing information
-Pharmacology/toxicology
-Previous human research/literature information
-Additional information (drug dependence and abuse potential)

How many days after FDA receives IND submission does the IND go into effect? (21 CFR
312.40) Correct Answer: An IND goes into effect 30 days after the FDA receives the
submission unless the FDA notifies the Sponsor of a clinical hold

When must an IND amendment be submitted? (21 CFR Part 312.31) Correct Answer: -If there
are changes to the protocol that affects safety of subjects, scientific quality of the study, or scope
of investigation
-If a new investigator is added to the study
-Information amendments must be submitted for chemistry/microbiology, pharm/toxicology, or
clinical
OTHER SUBMISSIONS:
--IND safety reports
--Response to clinical hold
--Response to FDA request for information
--IRB Annual report

What are t he requirements for expanded access? (21 CFR Part 312.300 - Subpart 1) Correct
Answer: -Population must have serious or life-threatening disease or condition
-No comparable/significant alternate therapy/treatment
-Patient cannot obtain drug under another IND or protocol
-Potential benefit outweighs risks of treatment
-Expanded access won't interfere with completion of studies that could support marketing
approval
-Must apply to treatment protocols and should be for individual use (1 person)

How many days does a Physician or Sponsor have to submit written summary of expanded
access to the FDA after use? Correct Answer: 15 days

, 21 CFR Part 312.34 Correct Answer: Treatment use of an Investigational new drug

During which phases is a treatment protocol usually made available? Correct Answer: During
Phase 3 but if data is compelling, may be available during Phase 2, OR, after all clinical trials
have been completed and Sponsor of trials is awaiting/pursuing marketing approval

How long is the waiting period before a treatment IND study can be initiated? Correct Answer:
30 days

When will the FDA permit use of an investigational drug in widespread use? Correct Answer: -
If the criteria for expanded access are met (benefits outweigh risk, illness is life threatening, or if
no other alternative treatments are available)
-If drug is being investigated in a controlled clinical trial under an IND designed to support a
marketing application for the expanded use or all clinical trials are completed

What are the steps for withdrawing an IND? (21 CFR Part 312.38) Correct Answer: A sponsor
may withdraw an IND at any time without prejudice by:
-Notifying the FDA
-Stopping all studies and notifying the investigators
-Returning all drug to the Sponsor, or destroying all drug as directed by Sponsor
-If the study is withdrawn for safety reasons, the Sponsor must notify investigators and the IRBs

Which form is used to certify absence of financial interest? Correct Answer: FDA Form 3454

What form is used for the mandatory reporting of serious adverse events? Correct Answer: FDA
Form 3500A

What is 21 CFR Part 50 Subpart D? Correct Answer: Additional Safeguards for Children in
Clinical Investigations

What is the FDA Form 482? Correct Answer: Notice of Inspection

What is 21 CFR Part 50.20 Subpart B? Correct Answer: General requirements for informed
consent

What steps must be taken if IND is put on clinical hold? (CFR Part 312.42) Correct Answer: -
Proposed study: Subjects may not be given the investigational drug
-Ongoing study: No recruiting of new subjects & subjects receiving investigational drug must
discontinue therapy unless specifically permitted by FDA in the interest of patient safety

What are the reasons for clinical hold? Correct Answer: -Exposure of unreasonable/significant
risk/injury to subjects
-Unqualified investigators (lack of scientific training/experience)
-Investigator brochure is misleading, erroneous, or incomplete
-IND does not contain sufficient information to assess risk to subjects of proposed studies

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Classroom. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

70055 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$10.49  1x  sold
  • (0)
  Add to cart